---
schema_version: "secwatch.filing_event.v1"
accession: "0000885725-23-000038"
form_type: "8-K"
ticker: "BSX"
cik: "0000885725"
company_name: "BOSTON SCIENTIFIC CORP"
filed_at: "2023-06-27T23:59:59+00:00"
generated_at: "2026-06-13T16:43:12.978951+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Boston Scientific elects Jessica L. Mega and Susan E. Morano to board of directors

## Summary
- Dr. Mega is co-founder of Verily Life Sciences (Alphabet) and former chief medical officer; cardiologist at Brigham & Women's.
- Ms. Morano was VP of Business Development and Strategic Operations at Johnson & Johnson MedTech until Feb 2023.
- Board expanded from 10 to 11; appointments effective June 27, 2023, with prorated cash retainer ~$97,715 and equity award ~$174,188.
- Dr. Mega joins Compensation and Risk Committees; Ms. Morano joins Audit and Nominating & Governance Committees.

## SEC filing metadata
- accession: 0000885725-23-000038
- form_type: 8-K
- ticker: BSX
- cik: 0000885725
- company_name: BOSTON SCIENTIFIC CORP
- filed_at: 2023-06-27T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/885725/000088572523000038/0000885725-23-000038-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/885725/000088572523000038/bsx-20230627.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000885725-23-000038
- JSON: https://secwatch.observer/filing/0000885725-23-000038.json
- Plain text: https://secwatch.observer/filing/0000885725-23-000038.txt

## Key facts
- Executive change
  Jessica L. Mega was appointed as director at BOSTON SCIENTIFIC CORP.
  - Action: appointed
  - Role: director
  source text: appointed each of Jessica L. Mega, MD, MPH and Susan E. Morano to be a director of the Company, to hold office until the next annual meeting of stockholders, in each case, effective June 27, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/885725/000088572523000038/0000885725-23-000038-index.htm
- Executive change
  Susan E. Morano was appointed as director at BOSTON SCIENTIFIC CORP.
  - Action: appointed
  - Role: director
  source text: appointed each of Jessica L. Mega, MD, MPH and Susan E. Morano to be a director of the Company, to hold office until the next annual meeting of stockholders, in each case, effective June 27, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/885725/000088572523000038/0000885725-23-000038-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.